Reported about 1 month ago
CVS Health has appointed David Joyner as CEO, replacing Karen Lynch, as investor pressure mounts to revitalize the company's stagnant stock performance. The announcement comes alongside the withdrawal of CVS's 2024 profit forecast and a significant downgrade in third-quarter earnings expectations, which fell well below analyst predictions. While CVS strives to integrate its businesses following the Aetna acquisition, it faces challenges from increasing healthcare costs and competition within the retail pharmacy sector.
Source: YAHOO